About the Authors
- Geoff P Garnett, Simon Gregson
- Imperial College London, London, United Kingdom
- Simon Gregson, Peter R Mason
- Biomedical Research and Training Institute, Harare, Zimbabwe
GPG has acted as a consultant for and/or received grants from GlaxoSmithKline, Aventis Pasteur, Merck, and Abbott Pharmaceuticals. GPG also chaired a meeting of the World Health Organization in 2003 to develop a consensus on the importance of unsafe injections in HIV epidemiology. SG owns shares in GlaxoSmithKline Beecham and Astra Zeneca.